ONHAOptic Nerve Head Analyzer
References in periodicals archive ?
In filing comments, ONHA urged the commissioners to reconsider placing I-Health/Martek under order because of its potential effect on future studies.
More specifically, ONHA stated: "if the Commission pursues an enforcement action against the Companies based upon questioning the analysis in the published MIDAS Study, it will establish a regulatory paradigm that will adversely affect consumers because advertisers will refrain from providing truthful and nonmisleading information about their products for fear of government prosecution.
Moreover, ONHA noted that the proposed consent decree would "likely have the perverse effect of disincentivizing advertisers from spending the time, money, and resources required to develop clinical studies to support their claims.